PMC:7276972 / 1240-1515 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T20","span":{"begin":33,"end":39},"obj":"UBERON:0001969"},{"id":"T21","span":{"begin":75,"end":89},"obj":"CHEBI:53258;CHEBI:53258"},{"id":"T22","span":{"begin":137,"end":147},"obj":"SP_7"},{"id":"T23","span":{"begin":181,"end":189},"obj":"SP_7"}],"text":"1) previous allergic reaction to plasma exchange or its ingredients (i.e., sodium citrate), 2) two consecutive negative RT-PCR tests for SARS-CoV-2 at least 24 hours apart, 3) mild COVID-19 not requiring ICU admission and 4) terminally ill patients receiving palliative care."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":33,"end":39},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"1) previous allergic reaction to plasma exchange or its ingredients (i.e., sodium citrate), 2) two consecutive negative RT-PCR tests for SARS-CoV-2 at least 24 hours apart, 3) mild COVID-19 not requiring ICU admission and 4) terminally ill patients receiving palliative care."}

{"project":"LitCovid-PubTator","denotations":[{"id":"25","span":{"begin":137,"end":147},"obj":"Species"},{"id":"26","span":{"begin":240,"end":248},"obj":"Species"},{"id":"27","span":{"begin":75,"end":89},"obj":"Chemical"},{"id":"28","span":{"begin":12,"end":29},"obj":"Disease"},{"id":"29","span":{"begin":181,"end":189},"obj":"Disease"}],"attributes":[{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"Tax:2697049"},{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"Tax:9606"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"MESH:D000077559"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"MESH:D004342"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"1) previous allergic reaction to plasma exchange or its ingredients (i.e., sodium citrate), 2) two consecutive negative RT-PCR tests for SARS-CoV-2 at least 24 hours apart, 3) mild COVID-19 not requiring ICU admission and 4) terminally ill patients receiving palliative care."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T10","span":{"begin":12,"end":29},"obj":"Disease"},{"id":"T12","span":{"begin":12,"end":20},"obj":"Disease"},{"id":"T13","span":{"begin":137,"end":145},"obj":"Disease"},{"id":"T14","span":{"begin":181,"end":189},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0000605"},{"id":"A11","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0004980"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"1) previous allergic reaction to plasma exchange or its ingredients (i.e., sodium citrate), 2) two consecutive negative RT-PCR tests for SARS-CoV-2 at least 24 hours apart, 3) mild COVID-19 not requiring ICU admission and 4) terminally ill patients receiving palliative care."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T13","span":{"begin":33,"end":39},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T14","span":{"begin":127,"end":132},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"1) previous allergic reaction to plasma exchange or its ingredients (i.e., sodium citrate), 2) two consecutive negative RT-PCR tests for SARS-CoV-2 at least 24 hours apart, 3) mild COVID-19 not requiring ICU admission and 4) terminally ill patients receiving palliative care."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":75,"end":89},"obj":"Chemical"},{"id":"T8","span":{"begin":75,"end":81},"obj":"Chemical"},{"id":"T9","span":{"begin":82,"end":89},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_53258"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_26708"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_133748"},{"id":"A10","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_16947"},{"id":"A11","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_50744"}],"text":"1) previous allergic reaction to plasma exchange or its ingredients (i.e., sodium citrate), 2) two consecutive negative RT-PCR tests for SARS-CoV-2 at least 24 hours apart, 3) mild COVID-19 not requiring ICU admission and 4) terminally ill patients receiving palliative care."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T7","span":{"begin":40,"end":51},"obj":"http://purl.obolibrary.org/obo/GO_0015297"}],"text":"1) previous allergic reaction to plasma exchange or its ingredients (i.e., sodium citrate), 2) two consecutive negative RT-PCR tests for SARS-CoV-2 at least 24 hours apart, 3) mild COVID-19 not requiring ICU admission and 4) terminally ill patients receiving palliative care."}

{"project":"LitCovid-sentences","denotations":[{"id":"T15","span":{"begin":0,"end":275},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"1) previous allergic reaction to plasma exchange or its ingredients (i.e., sodium citrate), 2) two consecutive negative RT-PCR tests for SARS-CoV-2 at least 24 hours apart, 3) mild COVID-19 not requiring ICU admission and 4) terminally ill patients receiving palliative care."}